Abstract:Background and Aim: By Affymatrix SNP6 array screening for copy number variations in gastric cancer (GC), we identified the nuclear protein-coding gene C8orf76 (chromosome 8 open reading frame 76) to be preferentially amplified in primary gastric tumors.However, the role of C8orf76 in human cancer remains unknown.This study aimed to elucidate the biological function, molecular mechanism and clinical significance of C8orf76 in GC.Methods: C8orf76 copy number was quantified by TaqMan qPCR assays.C8orf76 expression was assessed by RT-qPCR and immunohistochemistry. Molecular networks were investigated by RNA sequencing and pathway luciferase reporter assays.Direct downstream genes were elucidated by chromatin immunoprecipitation (ChIP)-sequencing.ChIP-PCR, luciferase reporter and electrophoretic mobility shift assay (EMSA) were performed to detect the binding effect of C8orf76 on candidate DNA motifs.Results: C8orf76 copy number was significantly increased in GC tumors compared to adjacent non-tumor tissues ( P<0.01).Consistently, C8orf76 mRNA and protein were significantly up-regulated in GC tumors compared to adjacent non-tumor tissues (both P<0.001).C8orf76 mRNA expression was positively correlated with its copy number in GC (n=66, R=0.64, P<0.0001), which was validated in TCGA cohort (n=414, R=0.74, P<0.0001).C8orf76 copy gain was significantly associated with advanced TNM stage ( P<0.05).Copy gain and overexpression of C8orf76 were significantly associated with poor prognosis in GC patients (both P<0.05).C8orf76 overexpression in GC cell line (AGS) and normal gastric epithelial cell line (GES1) significantly increased cell viability and clonogenicity, promoted G1-S cell cycle transition, inhibited apoptosis, and enhanced cell migration/invasion abilities (all P<0.05).Conversely, C8orf76 knockdown in GC cells (BGC823 and MKN28) exhibited opposite effects.In addition, MAPK signaling was activated by C8orf76 as identified by RNA sequencing, confirmed by increased SRE reporter activity ( P<0.001) and activation of ERK/2 and p38.The lncRNA DUSP5P1 was identified to be a downstream effector of C8orf76 by ChIP-sequencing and RNA-sequencing.Direct binding of C8orf76 protein to the DNA motif 'AGGCTG' at the promoter region of DUSP5P1 was verified by ChIP-PCR, luciferase reporter assay and EMSA.Expression of DUSP5P1 was positively correlated with C8orf76 levels in GC cells with C8orf76 overexpression or knockdown.Moreover, knockdown of DUSP5P1 could abolish the effects of C8orf76 on cell growth and MAPK activation.Conclusions: C8orf76 is a novel oncogenic factor that is commonly overexpressed in GC due to copy number gain.The tumor promoting effect of C8orf76 in GC was mediated by activating MAPK signaling through directly inducing lncRNA DUSP5P1.C8orf76 copy number and expression serve as potential prognostic biomarkers for GC patients.

Table S1-S13 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Su1241 - C8ORF76 Functions As a Novel Oncogene Via Directly Regulating Lncrna DUSP5P1 in Gastric Cancer

C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes.

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Figure S2 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Figure S1 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Figure S3 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

ZNF418 Overexpression Protects Against Gastric Carcinoma and Prompts a Good Prognosis

Identification Oftyrobpandc1qbas Two Novel Key Genes with Prognostic Value in Gastric Cancer by Network Analysis

Comprehensive Analysis Reveals CTHRC1, SERPINE1, VCAN and UPK1B As the Novel Prognostic Markers in Gastric Cancer.

DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance

Identification of Genes with A Correlation Between Copy Number and Expression in Gastric Cancer

Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer

Prognostic Impact of Aberrantly Expressed Protein-coding Gene Associated with Gastric Cancer's Regulatory T Cells, Based on Online Databases.

Recurrent Amplification of MYC and TNFRSF11B in 8q24 is Associated with Poor Survival in Patients with Gastric Cancer.

Screening for Amplification Genomic Loci and Genes Associated Prognosis in Gastric Cancer

USP13 Deubiquitinates and Stabilizes Cyclin D1 to Promote Gastric Cancer Cell Cycle Progression and Cell Proliferation

SPP1 Targeted by Mir-4262 in Gastric Cancer Functions As an Enhancer of Cell Growth and Correlates with Dismal Prognosis

Bioinformatics Analysis and Identification of Potential Genes Associated with Pathogenesis and Prognosis of Gastric Cancer

Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis.

Oncogenic USP22 Supports Gastric Cancer Growth and Metastasis by Activating C-Myc/nampt/sirt1-dependent FOXO1 and YAP Signaling